Press Releases Manufacturers of 10 Drugs Slated for Medicare Price Negotiation Spent Billions More on Buybacks, Dividends and Executive Compensation than R&D January 18, 2024
Fact Sheets & Backgrounders Expanding Access and Affordability to Taxpayer Funded Drugs: The Use of March-In Rights
Press Releases White House Takes Additional Steps Towards Fairer Pricing for Drugs Developed With Taxpayer Funding December 14, 2023
Press Releases White House March-In Plans Must Go Further to Challenge Big Pharma’s Monopoly Power December 7, 2023
Press Releases Analysis Shows Amgen’s Gaming Of Patent System Cost Medicare More Than a Billion in Savings Over Less Than Four Years October 31, 2023